Boris Mildner

813 total citations
22 papers, 501 citations indexed

About

Boris Mildner is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Boris Mildner has authored 22 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Boris Mildner's work include Cancer therapeutics and mechanisms (3 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers) and Virus-based gene therapy research (2 papers). Boris Mildner is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers) and Virus-based gene therapy research (2 papers). Boris Mildner collaborates with scholars based in Croatia, Germany and Netherlands. Boris Mildner's co-authors include Barbara B. Knowles, Ivan Damjanov, Chandra Prakash, Karmen Brajša, Snježana Čužić, Michael J. Parnham, Ines Glojnarić, Donatella Verbanac, Krunoslav Nujić and M. Z. I. Khan and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

Boris Mildner

22 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris Mildner Croatia 12 165 112 83 50 46 22 501
Joseph L. Skibba United States 21 298 1.8× 165 1.5× 125 1.5× 75 1.5× 31 0.7× 34 892
I Haberl Austria 12 142 0.9× 220 2.0× 65 0.8× 60 1.2× 29 0.6× 18 513
Masashi Uchida Japan 13 150 0.9× 146 1.3× 115 1.4× 48 1.0× 52 1.1× 44 543
Guy Mazué Italy 18 249 1.5× 124 1.1× 57 0.7× 31 0.6× 18 0.4× 37 904
A. A. Hartmann Germany 11 417 2.5× 72 0.6× 56 0.7× 18 0.4× 32 0.7× 35 708
Nicole M. Anders United States 19 313 1.9× 127 1.1× 118 1.4× 82 1.6× 20 0.4× 43 876
Angelika Bodenteich Austria 14 307 1.9× 96 0.9× 49 0.6× 97 1.9× 31 0.7× 24 764
Jeanne Féger France 19 544 3.3× 115 1.0× 73 0.9× 34 0.7× 27 0.6× 64 873
William McDowell Germany 12 383 2.3× 53 0.5× 71 0.9× 59 1.2× 27 0.6× 25 764
Li Cao United States 16 483 2.9× 123 1.1× 38 0.5× 70 1.4× 25 0.5× 36 908

Countries citing papers authored by Boris Mildner

Since Specialization
Citations

This map shows the geographic impact of Boris Mildner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Mildner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Mildner more than expected).

Fields of papers citing papers by Boris Mildner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Mildner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Mildner. The network helps show where Boris Mildner may publish in the future.

Co-authorship network of co-authors of Boris Mildner

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Mildner. A scholar is included among the top collaborators of Boris Mildner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Mildner. Boris Mildner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ralić, Jovica, et al.. (2013). A comparison of in vitro ADME properties and pharmacokinetics of azithromycin and selected 15-membered ring macrolides in rodents. European Journal of Drug Metabolism and Pharmacokinetics. 39(4). 263–276. 6 indexed citations
2.
Jelić, Dubravko, Boška Hrvačić, Karmen Brajša, et al.. (2012). Porphyrins as new endogenous anti-inflammatory agents. European Journal of Pharmacology. 691(1-3). 251–260. 15 indexed citations
3.
Kos, Vesna Munić, Krunoslav Nujić, Snježana Čužić, et al.. (2012). Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin. Pharmacological Research. 66(4). 332–342. 24 indexed citations
4.
Fučić, Aleksandra, Darko Marković, Zdenko Herceg, et al.. (2008). Developmental and transplacental genotoxicology: Fluconazole. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 657(1). 43–47. 12 indexed citations
5.
Čužić, Snježana, et al.. (2007). Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression. European Journal of Pharmacology. 570(1-3). 212–221. 78 indexed citations
6.
Jelić, Dubravko, Boris Mildner, Sanja Koštrun, et al.. (2007). Homology Modeling of Human Fyn Kinase Structure:  Discovery of Rosmarinic Acid as a New Fyn Kinase Inhibitor and in Silico Study of Its Possible Binding Modes. Journal of Medicinal Chemistry. 50(6). 1090–1100. 33 indexed citations
7.
Fučić, Aleksandra, et al.. (2005). Comparison of genomic damage caused by 5-nitrofurantoin in young and adult mice using the in vivo micronucleus assay. Environmental and Molecular Mutagenesis. 46(1). 59–63. 9 indexed citations
8.
Parnham, Michael J., et al.. (2004). The novel antifungal agent PLD‐118 is neither metabolized by liver microsomes nor inhibits cytochrome P450 in vitro. Biopharmaceutics & Drug Disposition. 26(1). 27–33. 8 indexed citations
9.
Khan, M. Z. I., et al.. (2004). Classification of Loratadine Based on the Biopharmaceutics Drug Classification Concept and Possible in Vitro-in Vivo Correlation. Biological and Pharmaceutical Bulletin. 27(10). 1630–1635. 57 indexed citations
10.
Veljača, Marija, Boris Mildner, Karmen Brajša, et al.. (2002). Safety, tolerability and pharmacokinetics of PL 14736, a novel agent for treatment of ulcerative colitis, in healthy male volunteers.. 74. 24 indexed citations
11.
Veljača, Marija, et al.. (2001). The development of PL 14736 for treatment of inflammatory bowel disease. Inflammopharmacology. 10. 564–565. 14 indexed citations
12.
Sikirić, Predrag, Marijan Petek, Rudolf Ručman, et al.. (1992). The significance of the gastroprotective effect of body protection compound (BPC): modulation by different procedures.. PubMed. 80(1-4). 89–98. 7 indexed citations
13.
Prakash, Chandra, et al.. (1981). Biochemical and immunological characterization of cellular DNA polymerases alpha, beta and gamma, and a reverse transcriptase from human melanoma tissue.. PubMed. 27(2-3). 239–51. 2 indexed citations
14.
Prakash, Chandra & Boris Mildner. (1979). [Molecular mechanism of action of diamidinephenylindole (DAPH) III. Physico-chemical binding of DAPI and its derivatives to DNA and polydeoxynucleotides, and its consequences on the template activity of nucleic acids (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 25(6). 429–33. 2 indexed citations
15.
Mildner, Boris, et al.. (1978). [Effect of methergolins on macromolecule synthesis in the brain].. PubMed. 28(1). 25–9. 2 indexed citations
16.
17.
Prakash, Chandra, et al.. (1978). Biochemical and immunological characterization of a reverse transcriptase from human melanoma tissue. Cancer Letters. 5(6). 299–310. 12 indexed citations
18.
Prakash, Chandra, Linda K. Steel, H. Laube, et al.. (1977). MOLECULAR APPROACHES TO INHIBIT ONCOGENESIS BY RNA TUMOR VIRUSES. Annals of the New York Academy of Sciences. 284(1). 444–462. 9 indexed citations
19.
Prakash, Chandra, et al.. (1977). Influence of 4?-6-diamidino-2-phenylindole on the secondary structure and template activities of DNA and polydeoxynucleotides. Molecular and Cellular Biochemistry. 18(2-3). 81–86. 16 indexed citations
20.
Prakash, Chandra, et al.. (1977). Chemical inhibitors of oncornaviral DNA polymerases: Biological implications, and their mode of action. 1(3). 231–287. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph L. Skibba Breakdown of academic impact, for papers by I Haberl Breakdown of academic impact, for papers by Masashi Uchida Breakdown of academic impact, for papers by Guy Mazué Breakdown of academic impact, for papers by A. A. Hartmann Breakdown of academic impact, for papers by Nicole M. Anders Breakdown of academic impact, for papers by Angelika Bodenteich Breakdown of academic impact, for papers by Jeanne Féger Breakdown of academic impact, for papers by William McDowell Breakdown of academic impact, for papers by Li Cao
Rankless by CCL
2026